Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label, v3.4.2, was added to the history. The deleted notices include a government funding status notice and the older v3.4.1 entry, reflecting administrative updates to the page's version history.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a general site status notice about government funding lapse and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check28 days agoChange DetectedThe history view now includes a glossary toggle and color-coded diffs (green for additions, red for deletions) with explicit revision notes (e.g., Revision: v3.4.0) to improve clarity of changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedMinor site revision update from v3.3.3 to v3.3.4; it does not alter study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.3.3 was added to the record history and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded a new revision entry (v3.3.2) and removed the previous entry (v3.3.1) in the page's version history, affecting only metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.